Deutsche Bank Ag\ Atea Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 49,567 shares of AVIR stock, worth $167,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,567

Previous 32,449 52.75%

Holding current value

$167,040

Previous $107,000 55.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $54,264 - $68,814	17,118 Added 52.75%	49,567 $166,000
Q2 2024 Aug 14, 2024	SELL	$3.31 - $4.04 $26,284 - $32,081	-7,941 Reduced 19.66%	32,449 $107,000
Q1 2024 May 15, 2024	BUY	$3.09 - $4.56 $5,917 - $8,732	1,915 Added 4.98%	40,390 $163,000
Q4 2023 Feb 14, 2024	SELL	$2.8 - $3.35 $5,171 - $6,187	-1,847 Reduced 4.58%	38,475 $117,000
Q3 2023 Nov 09, 2023	BUY	$3.0 - $3.79 $9,009 - $11,381	3,003 Added 8.05%	40,322 $120,000
Q2 2023 Aug 14, 2023	SELL	$3.21 - $5.06 $63,837 - $100,628	-19,887 Reduced 34.76%	37,319 $139,000
Q1 2023 May 15, 2023	BUY	$3.0 - $4.97 $77,166 - $127,838	25,722 Added 81.7%	57,206 $191,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $2,218 - $3,146	510 Added 1.65%	31,484 $151,000
Q3 2022 Nov 14, 2022	SELL	$5.49 - $8.79 $1.29 Million - $2.07 Million	-235,604 Reduced 88.38%	30,974 $176,000
Q2 2022 Aug 11, 2022	BUY	$5.33 - $8.18 $105,448 - $161,833	19,784 Added 8.02%	266,578 $1.89 Million
Q1 2022 May 13, 2022	BUY	$5.5 - $9.19 $954,684 - $1.6 Million	173,579 Added 237.08%	246,794 $1.78 Million
Q4 2021 Feb 11, 2022	SELL	$7.67 - $44.59 $158,707 - $922,656	-20,692 Reduced 22.03%	73,215 $654,000
Q3 2021 Nov 04, 2021	BUY	$21.33 - $35.06 $1.18 Million - $1.93 Million	55,150 Added 142.3%	93,907 $3.29 Million
Q2 2021 Aug 11, 2021	BUY	$19.22 - $59.08 $558,302 - $1.72 Million	29,048 Added 299.19%	38,757 $833,000
Q1 2021 May 13, 2021	SELL	$41.42 - $88.44 $36,656 - $78,269	-885 Reduced 8.35%	9,709 $599,000
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $279,257 - $442,617	10,594 New	10,594 $443,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account